Global Ascites Market Research Report - Forecast to 2023
Published: Dec-2018 | Format: PDF | Market Research Future | Number of pages: 122 | Code: MRS - 226858
Ascites is an abnormal accumulation fluid in the abdominal cavity. Liver cirrhosis is the most common case of ascites. Its presence is a sign of significant portal hypertension. Other less common factors that may contribute to ascites development are heart failure, kidney failure, cancers, and infection in pancreas. Malignant ascites has a characteristic role in the progression of ovarian cancer. Malignancy-related ascites have also been observed in malignancies of breast, lung, pancreas, gastric, and liver. Ascites can be detected by physical examination at a volume greater than 1.5 ascites. For smaller amount of fluid ultrasound, and CT scan are preferred.
Notably, rising prevalence of cirrhosis, improvement in reimbursement policies, and increasing occurrence of cancer are promoting the growth of ascites market globally. Ascites is a major complication of cirrhosis and is also an important landmark of chronic liver disease in the natural history. The rising alcohol consumption directly leads to the rising hospitalized cases and mortality due to alcoholic liver cirrhosis. Rising prevalence of cirrhosis and its related complications directly promotes the growth of ascites market.
However, complications associated with ascites treatment may hamper the market growth in coming future.
The global ascites market is expected to reach USD 3710.4 million by 2023 from USD 2806.1 million in 2016. This market is expected to grow at a stable CAGR of 4.0% during the forecast period d 2017-2023.
On the basis of type, the global ascites market is classified into transudative ascites, and exudate ascites. In 2016, exudate ascites segment commanded the largest market share of global ascites market by type segment.
On the basis of diagnosis, the global ascites ultrasound, CT scan, laparoscopy, angiography, and others. Ultrasound segment commanded the largest market share of 25.9% in 2016, and this segment is also expected to grow at a fastest CAGR of 4.4% during the forecast period 2017 to 2023.
On the basis of treatment, the global ascites market is segmented into surgeries, and others. Surgeries segment is further segmented into peritoneovenous shunting, liver transplantation, transjugular intrahepatic portosystemic shunt (TIPS), others. The surgeries market is projected to reach USD 2119.2 million by the end of 2023 at the CAGR of 4.3% during 2017 to 2023.
On the basis of end user, the global ascites market is segmented into hospitals & clinics, ambulatory surgical center, and diagnostic centers. The hospitals & clinics market is projected to reach USD 1,133.2 million by the end of 2023 at the CAGR of 4.4% during 2017 to 2023.
On the basis of regions, the market is segmented into Americas, Europe, Asia-Pacific and the Middle East & Africa. The Americas hold the largest share of the global ascites market and is expected to reach USD 1,292.2 million by 2023. Asia Pacific is the fastest growing market, which is expected to grow at a CAGR of 4.5% over the 2017-2023
Some of key the players in the ascites market are Sequana Medical, BioVie, PharmaCyte Biotech Inc., Fresenius SE & Co. KGaA, BD, GI Supply, Medtronic plc, and others.
To provide comprehensive analysis of ascites industry and its sub-segments in the global market, thereby providing a detailed structure of the industry.
To provide detailed insights into the factors driving and restraining the growth of global ascites market.
To estimate the market size of global ascites from 2014 to 2023. Wherein, 2014 & 2015 would be the historic period, 2016 shall be the base year, and 2017 – 2023 will be forecast period for the study.
To analyze global ascites market, on the basis of four main geographies namely, Americas, Europe, Asia-Pacific, and Middle East & Africa.
To compare the products with respect to the various players in the market
To provide country wise market value analysis for various segments of ascites market
To understand the demand-supply scenario and provide gap analysis of the industry
To analyze and provide upcoming technologies and trends in ascites market
To provide strategic profiling of key companies (manufacturers and distributors) present across the globe, and comprehensively analyze their competitiveness/competitive landscape in this market.
Medical Device companies
Research and Development (R&D) Companies
Medical Research Laboratories
Academic Medical Institutes and Universities
Americas accounted for the largest market share in the global ascites market, It is estimated to reach USD 1,292.2 million by 2023
Exudate ascites type of ascites is expected to command the largest market share of 55.8%
The ultrasound segment is expected to command the largest market share of 9% over the review period and it is also expected to grow at the fastest CAGR of 4.4% during the forecast period 2017-2023
The reports also covers regional analysis
o North America
o South America
o Rest of Europe
• Asia Pacific
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
Table of Contents: 1 Report Prologue 2 Market Introduction 2.1 Research Objective 2.2 Assumptions & Limitations 2.2.1 Assumptions 2.2.2 Limitations 2.3 Market Structure 3 Research Methodology 3.1 Introduction 3.1.1 Primary Research Methodology 3.1.2 Secondary Research Methodology 3.1.3 Market Share Analysis 3.1.4 Trade Analysis 3.1.5 Market Pricing Approach 4 Market Dynamics 4.1 Introduction 4.2 Drivers 4.2.1 Rising Prevalence of Cirrhosis (Impact Weightage: 35%) 4.2.2 Improvement in Reimbursement Policies (Impact Weightage: 30%) 4.2.3 Increasing Occurrence of Cancer (Impact Weightage: 35%) 4.3 Restraints 4.3.1 Complications associated with the ascites treatment 4.4 Opportunity 4.4.1 Development of Innovative Treatment Options 4.5 Macroeconomic Indicators 5 Market Factor Analysis 5.1 Porter’s Five Forces Model 5.1.1 Bargaining Power of Suppliers 5.1.2 Bargaining Power of Buyers 5.1.3 Threat of New Entrants 5.1.4 Threat of Substitutes 5.1.5 Intensity of Rivalry 5.2 Value Chain Analysis: Global Ascites Market 5.2.1 R&D and Designing 5.2.2 Manufacturing 5.2.3 Distribution & Sales 5.2.4 Post-sales Monitoring 5.3 Demand & Supply: Gap Analysis 5.4 Pricing Analysis 6 Global Ascites Market by Types 6.1 Introduction 6.2 Transudative Ascites 6.3 Exudate Ascites 7 Global Ascites Market by Diagnosis 7.1 Introduction 7.2 Ultrasound 7.3 CT scan 7.4 Laparoscopy 7.5 Angiography 8 Global Ascites Market by Treatment 8.1 Introduction 8.2 Surgeries 9 Global Ascites Market by End Users 9.1 Introduction 9.2 Hospitals & Clinics 9.3 Ambulatory Surgical Center 9.4 Diagnostic Centres 10 Global Ascites Market by Regions 10.1 Introduction 10.2 Americas 10.2.1 North America 10.2.1.1 US 10.2.1.2 Canada 10.2.2 South America 10.2.2.1 Brazil 10.2.2.2 Colombia 10.2.2.3 Mexico 10.2.2.4 Rest of South America 10.3 Europe 10.3.1 Western Europe 10.3.1.1 Germany 10.3.1.2 France 10.3.1.3 UK 10.3.1.4 Italy 10.3.1.5 Spain 10.3.1.6 Rest of Western Europe 10.3.2 Eastern Europe 10.4 Asia Pacific 10.4.1 China 10.4.2 Japan 10.4.3 India 10.4.4 Australia 10.4.5 Republic of Korea 10.4.6 Rest of Asia Pacific 10.5 Middle East & Africa 10.5.1 Middle East 10.5.1.1 UAE 10.5.1.2 Saudi Arabia 10.5.1.3 Oman 10.5.1.4 Kuwait 10.5.1.5 Qatar 10.5.1.6 Rest of Middle East 10.5.2 Africa 11 Competitive Analysis 11.1 Sequana Medical 11.1.1 Company Overview 11.1.2 Financials 11.1.3 Products 11.1.4 Strategy 11.1.5 Key Developments 11.2 BioVie 11.2.1 Company Overview 11.2.2 Financials 11.2.3 Products 11.2.4 Strategy 11.2.5 Key Developments 11.3 PharmaCyte Biotech Inc. 11.3.1 Company Overview 11.3.2 Financials 11.3.3 Products 11.3.4 Strategy 11.3.5 Key Developments 11.4 Fresenius SE & Co. KGaA 11.4.1 Company Overview 11.4.2 Financials 11.4.3 Products 11.4.4 Strategy 11.4.5 Key Developments 11.5 BD 11.5.1 Company Overview 11.5.2 Financials 11.5.3 Products 11.5.4 Strategy 11.5.5 Key Developments 11.6 GI Supply 11.6.1 Company Overview 11.6.2 Financials 11.6.3 Products 11.6.4 Strategy 11.6.5 Key Developments 11.7 Medtronic 11.7.1 Company Overview 11.7.2 Financials 11.7.3 Products 11.7.4 Strategy 11.7.5 Key Developments 12 Conclusion 12.1 Key Findings 12.1.1 From CEO’s View Point 13 Appendix 13.1 Discussion Blue Print
Inquiry For Buying
Market Research of Sulfur Dioxide Industry in China 2018-2022
Market Research on 2-Naphthol Industry in China 2018-2022
Market Analysis of Cellulose Ethers Industry in China 2018-2022
Market Research and Forecast of Deep Sea Fishing Vessel Industry in China 2018-2022
Market Analysis of Modified Plastics Industry in China 2018-2022View More
Global Chitosan Market Set for Rapid Growth, To Reach USD 4.74 Billion by 2021
Zion Market Research has published a new report titled Chitosan Market for Water Treatment, Biomed
Development of e-commerce to Reshape Global Mobile Hotspot Router Market
Mobile hotspot is a popular feature on smart phones that provide wireless internet access on many
Global Carotenoids Market Is Expected To Reach Around USD 1.52 Billion in 2021
Zion Market Research has published a new report titled Carotenoids Market by Type (Astaxanthin, Be
Soaring Demand from Food & Beverages Industry to Act as Prime Driving for Ascorbic Acid Market, Reports Zion Market Research
Ascorbic acid is extensively available in nature, mostly rich in leafy vegetables and fresh fruits
Global Energy Management System (EMS) Market Is Set for a Rapid Growth and is Expected to Reach USD 63,161.5 million by 2021
Zion Market Research has published a new report titled Energy Management System Market (EMS) by So